As programs approach commercial launch—or require additional supply—manufacturing capacity can quickly become a critical constraint.
At our Ferentino, Italy, site, commercial lyophilization capacity is currently available for selected programs. This creates an opportunity to secure capacity now and follow an accelerated, structured pathway toward commercial manufacturing.
Don’t wait for capacity to become a critical constraint to the progress of your program. Start the conversation today by clicking below.
A streamlined approach designed to move eligible programs from technology transfer to PPQ manufacturing in as little as 9 months.*
Move forward with confidence. If an agreed milestone is missed by more than two weeks, a 1% payback applies for each missed milestone, up to 5%.*
Support for drug products across 2R–20R and 20 mL vial formats, with additional configurations evaluated based on program requirements.
Established commercial manufacturing capacity is currently available for selected programs, helping you plan your path to market.
Start the conversation while this capacity is still available.
*Target timeline and pay-for-performance commitment are subject to agreed project scope, milestones, program requirements and applicable terms. Payback applies when an agreed milestone is missed by more than two weeks, at 1% per missed milestone, up to a maximum of 5%.